台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

MP031: Application of a single camera stereoscopic endoscope in urology surgery: A cases study on surgeon

2017-06-01 • 觀看: 2187 • 回應: 0 • doc
MP030: Androgen deprivation therapy duration is associated with abiraterone acetate efficacy in metastatic castration resistance prostate cancer

2017-06-01 • 觀看: 2017 • 回應: 0 • doc
MP029: Positive predictive value of multiparametric magnetic resonance imaging in prostate cancer detection: the experience of Tungs’ Taichung Metroharbor Hospital

2017-06-01 • 觀看: 2147 • 回應: 0 • doc
MP028: High-intensity focused ultrasound (HIFU) therapy for localized prostate cancer : Cathy General Hospital experience

2017-06-01 • 觀看: 2451 • 回應: 0 • doc
MP027: Efficacy and safety of enzalutamide (ENZ) vs placebo (PL) in chemotherapy- naïve patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC): Taiwan subgroup analysis of an Asian multiregional study

2017-06-01 • 觀看: 3397 • 回應: 0 • doc
MP026: The impact of different treatment modality in global quality of life among patients of prostate cancer

2017-06-01 • 觀看: 1968 • 回應: 0 • doc
MP025: Urodynamic changes in patients with prostate cancer who have undergone robotic-assisted radical prostatectomy: a comparison with laparoscopic radical prostatectomy

2017-06-01 • 觀看: 1977 • 回應: 0 • doc
MP024: Prognosis of prostate cancer with initial PSA at diagnosis beyond 1000 ng/ml

2017-06-01 • 觀看: 1847 • 回應: 0 • doc
MP023: Outcome of patients with metastatic castration-resistant prostate cancer after progressive disease of abiraterone acetate

2017-06-01 • 觀看: 2045 • 回應: 0 • doc
MP022: The value of prostate health index to predict magnetic resonance imaging lesions during active surveillance: A prospective cohort in Taiwan

2017-06-01 • 觀看: 2125 • 回應: 0 • doc
MP021: Prostate health index (PHI) improve prostate cancer detection at initial biopsy in Taiwanese men with PSA 4-10ng/ml

2017-06-01 • 觀看: 2163 • 回應: 0 • doc
2017TUA 形象影片0505

2017-06-01 • 觀看: 1 • 回應: 0 • 影片